Login to Your Account

Ripping Off the Band-Aid

Arena Gets $100M Loan as Lorcaserin Deal Talks Continue

By Trista Morrison

Thursday, June 18, 2009
Arena Pharmaceuticals Inc. obtained a $100 million credit facility from its largest shareholder, Deerfield Management, providing much-needed funding to propel obesity drug lorcaserin through FDA review and add muscle to ongoing partnership discussions. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription